Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 May;102(3):347-52.
doi: 10.1007/s11060-010-0337-z. Epub 2010 Aug 14.

Association of matrix metalloproteinase-1 gene polymorphism with glioblastoma multiforme in a northern Indian population

Affiliations

Association of matrix metalloproteinase-1 gene polymorphism with glioblastoma multiforme in a northern Indian population

Nitin Malik et al. J Neurooncol. 2011 May.

Abstract

Matrix metalloproteinase-1 (MMP-1) is known to be involved in the pathogenesis of glioma. It damages the extra-cellular matrix to produce invasiveness in cancer tissue, and hence has a direct effect in cancer invasion. The study aims to explore the association of single nucleotide polymorphism of -1607 MMP-1 gene with susceptibility to glioblastoma multiforme (GBM) in northern Indian subjects. One hundred and ten GBM patients and 150 healthy controls were included in this study. 1607 MMP-1 gene was studied by PCR-RFLP; different genotypes being combinations of 1G and 2G allele (1G/1G, 1G/2G and 2G/2G). 2G/2G genotype was significantly associated with GBM patients (OR, 2.24; P = 0.016; 95% CI, 1.16-4.30) as compared to controls. Prevalence of the 2G allele of -1607 MMP-1 polymorphism was significantly greater in GBM patients as compared to controls (62.3 vs 48.3%, OR, 1.76; P = 0.002; 95% CI, 1.23-2.52). This study suggests that the 2G/2G genotype and 2G allele of -1607 MMP-1 polymorphism are associated with an increased susceptibility for developing GBM.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Annu Rev Cell Dev Biol. 2001;17:463-516 - PubMed
    1. J Neurooncol. 2002 Jan;56(2):149-58 - PubMed
    1. BMC Cancer. 2007 Oct 05;7:187 - PubMed
    1. Clin Cancer Res. 2000 Dec;6(12):4823-30 - PubMed
    1. Nat Med. 1996 Apr;2(4):461-2 - PubMed

Substances

LinkOut - more resources